Ventrus Biosciences, Inc. (Nasdaq: VTUS) announced today that it is concurrently offering to sell, subject to market and other conditions ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE